Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 110Carcinoma, Intraductal, Noninfiltrating 7Breast Carcinoma In Situ 6Neoplasms 4Neoplasm Metastasis 3Inflammatory Breast Neoplasms 3Carcinoma, Ductal, Breast 3Breast Neoplasms, Male 3Fallopian Tube Neoplasms 2Endometrial Neoplasms 2Breast Cancer Female 2Sleep Wake Disorders 1Quality of Life 1Pulmonary Fibrosis 1Prostatic Neoplasms 1Primary Breast Cancer 1Paget's Disease, Mammary 1Ovarian Neoplasms 1Obesity 1Neoplasm Recurrence, Local 1Liver Neoplasms 1Infertility 1Hot Flashes 1Fatigue 1Cardiotoxicity 1Carcinoma, Ovarian Epithelial 1Carcinoma, Lobular 1Carcinoma, Hepatocellular 1Breast Cancer Subjects 1Bone Density 1

Interventions

tislelizumab 1motexafin gadolinium 1Tamoxifen 1Talaporfin 1Radiotherapy 1Oxaliplatin 1Mitomycin 1Lomustine 1Irinotecan 1Gemcitabine 1Folfox protocol 1Fluorouracil 1Ethiodized Oil 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Neoplasm Recurrence, Local × Tamoxifen × Clear all
NCT01357772 2023-07-17

TAM-01

Ente Ospedaliero Ospedali Galliera

Phase 3 Active not recruiting
500 enrolled
Breast

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Neoplasm Recurrence, Local

Data powered by HemOnc (CC BY 4.0) Colophon âš¡